422 related articles for article (PubMed ID: 2888712)
1. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
Wolf ME; DeWolfe AS; Mosnaim AD
Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712
[TBL] [Abstract][Full Text] [Related]
2. Vulnerability to tardive dyskinesia.
Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
[TBL] [Abstract][Full Text] [Related]
3. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
Wolf ME; Chevesich J; Lehrer E; Mosnaim AD
Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032
[No Abstract] [Full Text] [Related]
4. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
Akbostanci MC; Atbaşoğlu EC; Balaban H
Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
[TBL] [Abstract][Full Text] [Related]
5. Comparison of severe and mild tardive dyskinesia: implications for etiology.
Gardos G; Cole JO; Schniebolk S; Salomon M
J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
[TBL] [Abstract][Full Text] [Related]
6. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
Kane JM
J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
[TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia and the primary psychiatric diagnosis.
Yassa R; Nair V; Schwartz G
Psychosomatics; 1984 Feb; 25(2):135-8. PubMed ID: 6142494
[No Abstract] [Full Text] [Related]
8. Prevention and management of tardive dyskinesia.
Jeste DV; Wyatt RJ
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
[TBL] [Abstract][Full Text] [Related]
9. Tardive dyskinesia and impaired glucose tolerance.
Chong SA; Mythily ; Lum A; Huak CY; Kane J
Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
[TBL] [Abstract][Full Text] [Related]
10. [Psychopathology and cognitive disorders in chronic schizophrenic patients with tardive dyskinesia].
Kaiser W
Nervenarzt; 1989 Apr; 60(4):206-12. PubMed ID: 2566936
[No Abstract] [Full Text] [Related]
11. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
Barnes TR
Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
[TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia and glucid metabolism.
Brousse G; Meary A; Mouret J; Blanc O; Hueber T; Lemoine P; Llorca PM; Lachaux B
Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
[TBL] [Abstract][Full Text] [Related]
13. Clinical and epidemiologic aspects of tardive dyskinesia.
Baldessarini RJ
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
Chacko RC; Root L; Marmion J; Molinari V; Adams GL
J Clin Psychiatry; 1985 Feb; 46(2):55-7. PubMed ID: 2857168
[TBL] [Abstract][Full Text] [Related]
15. [Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
Bourgeois M
Encephale; 1977; 3(4):299-320. PubMed ID: 611013
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia.
Jeste DV; Neckers LM; Wagner RL; Wise CD; Staub RA; Rogol A; Potkin SG; Bridge TP; Wyatt RJ
J Clin Psychiatry; 1981 Feb; 42(2):75-7. PubMed ID: 6109719
[TBL] [Abstract][Full Text] [Related]
17. Factors related to the severity of tardive dyskinesia.
Wade JB; Hart RP; Dougherty LM
Brain Cogn; 1993 Sep; 23(1):71-80. PubMed ID: 8105823
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
Richardson MA; Haugland G; Craig TJ
Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
[TBL] [Abstract][Full Text] [Related]
19. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
[TBL] [Abstract][Full Text] [Related]
20. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
Dean CE; Kuskowski MA; Caligiuri MP
J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]